Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05359692
Title INCAGN01876 in Combination With Immunotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Incyte Biosciences International Sarl
Indications

oral squamous cell carcinoma

laryngeal squamous cell carcinoma

oropharynx cancer

hypopharynx cancer

Therapies

INCAGN01876 + Retifanlimab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.